top of page

LATEST NEWS

Improving the quality and longevity of patients’ lives

April 18, 2023

2023 Midwest Growth Capital Symposium to Feature Louis Cannon and Dug Song as Keynotes   

    >> Read More

April 11, 2023

AVS Appoints Sean Gilligan as Chief Operating Officer

    >> Read More

April 4, 2023

AVS’s Pulsatile Intravascular Lithotripsy Technology Attracts an Additional $8.8M to Close $28.8M Series B Round

    >> Read More

March 16, 2023

BioStar Capital, Top 20 Venture Capital Firm 2023: Fueling Medtech Innovations with Uncompromised Fund Performance (Financial Services Review)

    >> Read More

March 2, 2023

MMI Named One of Fast Company’s 2023 “World’s Most Innovative Companies”

    >> Read More

January 17, 2023

BioStar Capital in The Wall Street Journal: Venture Interest in Medical Devices Holds Up, but Investors Are Choosy   

    >> Read More

January 5, 2023

AVS Raises $20 Million in Series B Round to Advance Pulsatile Intravascular Lithotripsy (PIVL) Solutions

    >> Read More

January 4, 2023

MMI to Present at the 41st Annual J.P. Morgan Healthcare Conference

    >> Read More

September 15, 2022

AVS Announces Multi-Site Enrollment of First Patients in POWER PAD I Clinical Trial and Appointment of William H. Kucheman to Board of Directors

    >> Read More

September 13, 2022

MedTech Strategist Article: Foldax advances the Next Big Thing in Heart Valves: Robotic Manufacturing

    >> Read More

August 9, 2022

REVA Medical Announces Closing of Strategic Financing

    >> Read More

July 27, 2022

Medtech Money Podcast, Episode 85: Louis Cannon, Founder & Senior Managing Director at BioStar Capital   

    >> Read More

July 20, 2022

Medical Microinstruments Secures $75M to Advance Robotic Microsurgery

    >> Read More

July 12, 2022

Medtronic signs $585m option to buy Israeli medtech firm CathWorks

    >> Read More

June 17, 2022

Senseonics lands CE mark for 6-month CGM implant, teeing up Q3 launch in Europe

    >> Read More

June 13, 2022

Ablative Solutions, Inc. Announces Completion of the Fourth Tranche of its Series D Preferred Financing Round for Unique Therapeutic Approach to Treating Uncontrolled Hypertension

    >> Read More

June 10, 2022

REVA Medical presents 6-month results from MOTIV BTK pilot study

    >> Read More

May 24, 2022

REVA Medical announces final 5 year results for its FANTOM II coronary scaffold study

    >> Read More

May 11, 2022

This Company Is Reinventing the Heart Valve

    >> Read More

May 3, 2022

First Patients Outside of U.S. Treated with TRIA Biopolymer Surgical Aortic Heart Valve in India Clinical Trial

    >> Read More

March 30, 2022

Olympic Ophthalmics Announces FDA Clearance and Availability of Its Next-Generation iTEAR100 Neurostimulation Device, Expanded Patent Portfolio, and Further Clinical Studies

    >> Read More

January 18, 2022

Foldax Appoints Scott Huennekens to Board of Directors

    >> Read More

January 5, 2022

Senseonics expects FDA approval for next-gen 180-day CGM in ‘coming weeks’

    >> Read More

November 29, 2021

Mark Foster of Trice Medical Recognized As One of Ten Best CEOs of 2021

    >> Read More

September 29, 2021

TransMedics Receives FDA Approval for its OCS Liver System for Preservation and Assessment of Donor Livers for Transplantation

    >> Read More

September 7, 2021

TransMedics Receives FDA Approval for its OCS Heart System Enabling Broader Utilization of Donor Hearts for Transplantation in the U.S.­

    >> Read More

July 14, 2021

TransMedics Announces Positive FDA Advisory Committee Vote for the OCS Liver System

    >> Read More

June 13, 2021

Stryker announces the FDA clearance of the first biodegradable subacromial balloon spacer, filling a gap in the shoulder continuum of care

    >> Read More

June 10, 2021

TransMedics Announces Scheduling of OCS Liver FDA Advisory Committee Meeting

    >> Read More

June 8, 2021

TransMedics Announces Presentation of OCS Liver PROTECT Trial Results and is Recognized as Winner of The People's Choice Award for Most Impactful Presentation at the American Transplant Congress (ATC 2021)

    >> Read More

June 6, 2021

Arctic Vision Announces Exclusive Licensing Agreement with Olympic Ophthalmics for iTEAR®100 for the Treatment of Dry Eye Disease in Greater China, South Korea and ASEAN countries

    >> Read More

June 3, 2021

Senseonics Announces Results of the PROMISE Study Demonstrating Strong Accuracy of 180 Day CGM Sensor

    >> Read More

May 25, 2021

Foldax Announces Successful First Human Use of Tria Biopolymer Mitral Heart Valve

    >> Read More

May 25, 2021

Jeffrey Yau, PhD, VP of Data Science and Engineering at Walmart Global Technology, Joins BioStar Capital as Entrepreneur in Residence

    >> Read More

April 6, 2021

TransMedics Announces Positive FDA Advisory Committee Vote for OCS Heart System

    >> Read More

April 1, 2021

Trice Medical continues mission of making elective procedures more efficient through the acquisition of Tenex Health

    >> Read More

March 8, 2021

Foldax Named Among Fierce Medtech’s “Fierce 15” Companies of 2020

    >> Read More

January 19, 2021

Senseonics Announces a Positive Coverage Decision for Eversense CGM from EmblemHealth

    >> Read More

January 15, 2021

DeviceTalks Weekly features Mark Toland, BioStar Entrepreneur-in-Residence: Digging into the Digital Medtech & Surgical Worlds

    >> Read More

January 7, 2021

CathWorks Announces $30 Million in New Financing

    >> Read More

October 13, 2020

Foldax Named Cardiovascular Device Company of the Year by MedTech Outlook

    >> Read More

October 7, 2020

Foldax Strengthens Scientific and Medical Advisory Boards

    >> Read More

August 18, 2020

Foldax Named a Finalist in the Fierce Innovation Awards – Life Sciences Edition 2020

    >> Read More

June 22, 2020

Heart Valve Innovator Foldax Closes $20 Million Financing

    >> Read More

June 1, 2020

Foldax Wins 2020 MedTech Breakthrough Award for Cardiovascular Technology Innovation

    >> Read More

News Archives
bottom of page